Table of Content

1 Felodipine Sustained-Release Tablet Market Overview
1.1 Product Overview and Scope of Felodipine Sustained-Release Tablet
1.2 Felodipine Sustained-Release Tablet Segment by Type
1.2.1 Global Felodipine Sustained-Release Tablet Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5mg Per Tablet
1.2.3 5mg Per Tablet
1.2.4 Others
1.3 Felodipine Sustained-Release Tablet Segment by Application
1.3.1 Felodipine Sustained-Release Tablet Sales Comparison by Application: (2021-2027)
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Global Felodipine Sustained-Release Tablet Market Size Estimates and Forecasts
1.4.1 Global Felodipine Sustained-Release Tablet Revenue 2016-2027
1.4.2 Global Felodipine Sustained-Release Tablet Sales 2016-2027
1.4.3 Felodipine Sustained-Release Tablet Market Size by Region: 2016 Versus 2021 Versus 2027

2 Felodipine Sustained-Release Tablet Market Competition by Manufacturers
2.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2016-2021)
2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Felodipine Sustained-Release Tablet Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Felodipine Sustained-Release Tablet Manufacturing Sites, Area Served, Product Type
2.5 Felodipine Sustained-Release Tablet Market Competitive Situation and Trends
2.5.1 Felodipine Sustained-Release Tablet Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Felodipine Sustained-Release Tablet Players Market Share by Revenue
2.5.3 Global Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Felodipine Sustained-Release Tablet Retrospective Market Scenario by Region
3.1 Global Felodipine Sustained-Release Tablet Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Felodipine Sustained-Release Tablet Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.3.1 North America Felodipine Sustained-Release Tablet Sales by Country
3.3.2 North America Felodipine Sustained-Release Tablet Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.4.1 Europe Felodipine Sustained-Release Tablet Sales by Country
3.4.2 Europe Felodipine Sustained-Release Tablet Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Felodipine Sustained-Release Tablet Market Facts & Figures by Region
3.5.1 Asia Pacific Felodipine Sustained-Release Tablet Sales by Region
3.5.2 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.6.1 Latin America Felodipine Sustained-Release Tablet Sales by Country
3.6.2 Latin America Felodipine Sustained-Release Tablet Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.7.1 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country
3.7.2 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Felodipine Sustained-Release Tablet Historic Market Analysis by Type
4.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2016-2021)
4.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2016-2021)
4.3 Global Felodipine Sustained-Release Tablet Price by Type (2016-2021)

5 Global Felodipine Sustained-Release Tablet Historic Market Analysis by Application
5.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2016-2021)
5.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2016-2021)
5.3 Global Felodipine Sustained-Release Tablet Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Astrazeneca
6.1.1 Astrazeneca Corporation Information
6.1.2 Astrazeneca Description and Business Overview
6.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Astrazeneca Product Portfolio
6.1.5 Astrazeneca Recent Developments/Updates
6.2 NanJing Easeheal Phaemaecutical
6.2.1 NanJing Easeheal Phaemaecutical Corporation Information
6.2.2 NanJing Easeheal Phaemaecutical Description and Business Overview
6.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.2.4 NanJing Easeheal Phaemaecutical Product Portfolio
6.2.5 NanJing Easeheal Phaemaecutical Recent Developments/Updates
6.3 SHANXI KANGBO BIOLOGICAL PRODUCT
6.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
6.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
6.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Product Portfolio
6.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
6.4 Lifeon
6.4.1 Lifeon Corporation Information
6.4.2 Lifeon Description and Business Overview
6.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lifeon Product Portfolio
6.4.5 Lifeon Recent Developments/Updates
6.5 Changzhou Siyao Pharmaceutical
6.5.1 Changzhou Siyao Pharmaceutical Corporation Information
6.5.2 Changzhou Siyao Pharmaceutical Description and Business Overview
6.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Changzhou Siyao Pharmaceutical Product Portfolio
6.5.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Mylan Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz Product Portfolio
6.7.5 Sandoz Recent Developments/Updates

7 Felodipine Sustained-Release Tablet Manufacturing Cost Analysis
7.1 Felodipine Sustained-Release Tablet Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
7.4 Felodipine Sustained-Release Tablet Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Felodipine Sustained-Release Tablet Distributors List
8.3 Felodipine Sustained-Release Tablet Customers

9 Felodipine Sustained-Release Tablet Market Dynamics
9.1 Felodipine Sustained-Release Tablet Industry Trends
9.2 Felodipine Sustained-Release Tablet Growth Drivers
9.3 Felodipine Sustained-Release Tablet Market Challenges
9.4 Felodipine Sustained-Release Tablet Market Restraints

10 Global Market Forecast
10.1 Felodipine Sustained-Release Tablet Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Felodipine Sustained-Release Tablet by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Felodipine Sustained-Release Tablet by Type (2022-2027)
10.2 Felodipine Sustained-Release Tablet Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Felodipine Sustained-Release Tablet by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Felodipine Sustained-Release Tablet by Application (2022-2027)
10.3 Felodipine Sustained-Release Tablet Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Felodipine Sustained-Release Tablet by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Felodipine Sustained-Release Tablet by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Felodipine Sustained-Release Tablet Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Felodipine Sustained-Release Tablet Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Felodipine Sustained-Release Tablet Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Felodipine Sustained-Release Tablet Covered in This Study
Table 5. Global Felodipine Sustained-Release Tablet Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Felodipine Sustained-Release Tablet Sales Share by Manufacturers (2016-2021)
Table 7. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Felodipine Sustained-Release Tablet Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Felodipine Sustained-Release Tablet Manufacturing Sites and Area Served
Table 11. Manufacturers Felodipine Sustained-Release Tablet Product Type
Table 12. Global Felodipine Sustained-Release Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Felodipine Sustained-Release Tablet by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Felodipine Sustained-Release Tablet as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Felodipine Sustained-Release Tablet Sales by Region (2016-2021) & (K Units)
Table 16. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2016-2021)
Table 17. Global Felodipine Sustained-Release Tablet Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Felodipine Sustained-Release Tablet Sales by Country (2016-2021) & (K Units)
Table 19. North America Felodipine Sustained-Release Tablet Sales Market Share by Country (2016-2021)
Table 20. North America Felodipine Sustained-Release Tablet Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2016-2021)
Table 22. Europe Felodipine Sustained-Release Tablet Sales by Country (2016-2021) & (K Units)
Table 23. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2016-2021)
Table 24. Europe Felodipine Sustained-Release Tablet Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Region (2016-2021)
Table 30. Latin America Felodipine Sustained-Release Tablet Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Country (2016-2021)
Table 32. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2016-2021)
Table 38. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2016-2021)
Table 39. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2016-2021)
Table 40. Global Felodipine Sustained-Release Tablet Revenue (Million US$) by Type (2016-2021)
Table 41. Global Felodipine Sustained-Release Tablet Revenue Share by Type (2016-2021)
Table 42. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2016-2021)
Table 43. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2016-2021)
Table 44. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2016-2021)
Table 45. Global Felodipine Sustained-Release Tablet Revenue (Million US$) by Application (2016-2021)
Table 46. Global Felodipine Sustained-Release Tablet Revenue Share by Application (2016-2021)
Table 47. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2016-2021)
Table 48. Astrazeneca Corporation Information
Table 49. Astrazeneca Description and Business Overview
Table 50. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Astrazeneca Felodipine Sustained-Release Tablet Product
Table 52. Astrazeneca Recent Developments/Updates
Table 53. NanJing Easeheal Phaemaecutical Corporation Information
Table 54. NanJing Easeheal Phaemaecutical Description and Business Overview
Table 55. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product
Table 57. NanJing Easeheal Phaemaecutical Recent Developments/Updates
Table 58. SHANXI KANGBO BIOLOGICAL PRODUCT Corporation Information
Table 59. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
Table 60. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product
Table 62. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
Table 63. Lifeon Corporation Information
Table 64. Lifeon Description and Business Overview
Table 65. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Lifeon Felodipine Sustained-Release Tablet Product
Table 67. Lifeon Recent Developments/Updates
Table 68. Changzhou Siyao Pharmaceutical Corporation Information
Table 69. Changzhou Siyao Pharmaceutical Description and Business Overview
Table 70. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product
Table 72. Changzhou Siyao Pharmaceutical Recent Developments/Updates
Table 73. Mylan Corporation Information
Table 74. Mylan Description and Business Overview
Table 75. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Mylan Felodipine Sustained-Release Tablet Product
Table 77. Mylan Recent Developments/Updates
Table 78. Sandoz Corporation Information
Table 79. Sandoz Description and Business Overview
Table 80. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Sandoz Felodipine Sustained-Release Tablet Product
Table 82. Sandoz Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Felodipine Sustained-Release Tablet Distributors List
Table 86. Felodipine Sustained-Release Tablet Customers List
Table 87. Felodipine Sustained-Release Tablet Market Trends
Table 88. Felodipine Sustained-Release Tablet Growth Drivers
Table 89. Felodipine Sustained-Release Tablet Market Restraints
Table 90. Global Felodipine Sustained-Release Tablet Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Felodipine Sustained-Release Tablet Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Felodipine Sustained-Release Tablet Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Felodipine Sustained-Release Tablet Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Felodipine Sustained-Release Tablet Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Felodipine Sustained-Release Tablet Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Felodipine Sustained-Release Tablet Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Felodipine Sustained-Release Tablet Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Felodipine Sustained-Release Tablet
Figure 2. Global Felodipine Sustained-Release Tablet Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Per Tablet Product Picture
Figure 4. 5mg Per Tablet Product Picture
Figure 5. Others Product Picture
Figure 6. Global Felodipine Sustained-Release Tablet Market Share by Application in 2020 & 2027
Figure 7. Treat High Blood Pressure
Figure 8. Relieve Angina
Figure 9. Others
Figure 10. Global Felodipine Sustained-Release Tablet Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Felodipine Sustained-Release Tablet Market Size 2016-2027 (US$ Million)
Figure 12. Global Felodipine Sustained-Release Tablet Sales 2016-2027 (K Units)
Figure 13. Global Felodipine Sustained-Release Tablet Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Felodipine Sustained-Release Tablet Sales Share by Manufacturers in 2020
Figure 15. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Felodipine Sustained-Release Tablet Players: Market Share by Revenue in 2020
Figure 17. Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2016-2021)
Figure 19. Global Felodipine Sustained-Release Tablet Sales Market Share by Region in 2020
Figure 20. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2016-2021)
Figure 21. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region in 2020
Figure 22. United States Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. UK Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Felodipine Sustained-Release Tablet Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Felodipine Sustained-Release Tablet by Type (2016-2021)
Figure 47. Sales Market Share of Felodipine Sustained-Release Tablet by Application (2016-2021)
Figure 48. Sales Market Share of Felodipine Sustained-Release Tablet by Application in 2020
Figure 49. Revenue Share of Felodipine Sustained-Release Tablet by Application (2016-2021)
Figure 50. Revenue Share of Felodipine Sustained-Release Tablet by Application in 2020
Figure 51. Manufacturing Cost Structure of Felodipine Sustained-Release Tablet
Figure 52. Manufacturing Process Analysis of Felodipine Sustained-Release Tablet
Figure 53. Felodipine Sustained-Release Tablet Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed